Paul A. Carpenter

Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria

Mary E.D. Flowers, Yoshihiro Inamoto, Paul A. Carpenter et al. · Blood · 2011 · 681 citations · Full text

Life Sciences, Immunology, Epidemiology +14

Invasive Aspergillosis following Hematopoietic Cell Transplantation: Outcomes and Prognostic Factors Associated with Mortality

A. Upton, Katharine A. Kirby, Paul A. Carpenter et al. · Clinical Infectious Diseases · 2007 · 511 citations · Full text

Medicine, Hematology, Clinical Epidemiology +16

Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation

Navneet S. Majhail, Stephanie Farnia, Paul A. Carpenter et al. · Biology of Blood and Marrow Transplantation · 2015 · 409 citations · Full text

Medicine, Hematology, Cell Therapy +7

Ancillary Therapy and Supportive Care of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. Ancillary Therapy and Supportive Care Working Group Report

Daniel R. Couriel, Paul A. Carpenter, Corey Cutler et al. · Biology of Blood and Marrow Transplantation · 2006 · 320 citations

Life Sciences, Immunology, Infectious Diseases +16

Duration of immunosuppressive treatment for chronic graft-versus-host disease

Betty L. Stewart, Barry E. Storer, Jan Storek et al. · Blood · 2004 · 281 citations

Life Sciences, Immunology, Clinical Immunology +13